Compound ID | 3201
Synonym(s): Prothionamide
Class: Mycolic acid synthesis inhibitor
Details of activity: | Active against tuberculous and non-tuberculous mycobacterial infections; mycolic acid synthesis inhibitor (binds to enoyl-acyl ACP reductase InhA) |
Description: | Synthetic compound; pyridine derivative of ethionamide; may be included in treatment of MDR or rifampicin resistant TB (second-line anti-TB drug) |
Year first mentioned: | 1950 |
Highest developmental phase: | Phase 3 (NCT06081361) |
Development status: | Active (as of 2024) |
Chemical structure(s): | |||||||||||
|
|
External links: | |
PubChem link: | https://pubchem.ncbi.nlm.nih.gov/compound/666418 |
Citation: | https://www.sciencedirect.com/science/article/pii/0041387968900482?via%3Dihub |